Kate R Lorig1, Philip L Ritter1, Anna Jacquez2. 1. The Patient Education Research Center, Stanford University, Stanford, California (Ms Lorig, Mr Ritter) 2. Formerly from the El Paso Diabetes Association, El Paso, Texas (Ms Jacquez)
Abstract
PURPOSE: The purpose of this study was to evaluate the community-based Chronic Disease Self-management Program (CDSMP) and the Spanish-language version (Tomando Control de Su Salud) programs as delivered in settings along the Texas/New Mexico/Mexico border. The programs had proven effective in randomized trials, and the authors wished to determine if they would be as effective when administered by others to different populations. METHODS: The El Paso Diabetes Association administered the CDSMP and Tomando to 445 persons with chronic illness (two thirds with diabetes) in Texas, New Mexico, and Mexico. Four-month and 1-year outcomes were compared to baseline using t tests of change scores. Regression models were used to test whether baseline demographics and self-efficacy were associated with positive outcomes of the programs. RESULTS: Participants showed improvements in health behaviors, health status, and self-efficacy at both 4 month and 1 year. Baseline self-efficacy and 4-month change in self-efficacy were significantly associated with improved 1-year outcomes. CONCLUSIONS: The CDSMP and Tomando are effective when used in settings other than that of the original study for populations other than those for which they were initially developed.
PURPOSE: The purpose of this study was to evaluate the community-based Chronic Disease Self-management Program (CDSMP) and the Spanish-language version (Tomando Control de Su Salud) programs as delivered in settings along the Texas/New Mexico/Mexico border. The programs had proven effective in randomized trials, and the authors wished to determine if they would be as effective when administered by others to different populations. METHODS: The El Paso Diabetes Association administered the CDSMP and Tomando to 445 persons with chronic illness (two thirds with diabetes) in Texas, New Mexico, and Mexico. Four-month and 1-year outcomes were compared to baseline using t tests of change scores. Regression models were used to test whether baseline demographics and self-efficacy were associated with positive outcomes of the programs. RESULTS:Participants showed improvements in health behaviors, health status, and self-efficacy at both 4 month and 1 year. Baseline self-efficacy and 4-month change in self-efficacy were significantly associated with improved 1-year outcomes. CONCLUSIONS: The CDSMP and Tomando are effective when used in settings other than that of the original study for populations other than those for which they were initially developed.
Authors: Lorena M Salto; Zaida Cordero-MacIntyre; Lawrence Beeson; Eloy Schulz; Anthony Firek; Marino De Leon Journal: Diabetes Educ Date: 2011-02-22 Impact factor: 2.140
Authors: Brian W Pennarola; Angie Mae Rodday; Deborah K Mayer; Sara J Ratichek; Stella M Davies; Karen L Syrjala; Sunita Patel; Kristin Bingen; Mary Jo Kupst; Lisa Schwartz; Eva C Guinan; Judith H Hibbard; Susan K Parsons Journal: Med Care Res Rev Date: 2011-12-26 Impact factor: 3.929
Authors: Urmimala Sarkar; John D Piette; Ralph Gonzales; Daniel Lessler; Lisa D Chew; Brendan Reilly; Jolene Johnson; Melanie Brunt; Jennifer Huang; Marsha Regenstein; Dean Schillinger Journal: Patient Educ Couns Date: 2007-11-07
Authors: David X Marquez; JoEllen Wilbur; Susan L Hughes; Michael L Berbaum; Robert S Wilson; David M Buchner; Edward McAuley Journal: Contemp Clin Trials Date: 2014-06-24 Impact factor: 2.226